Natco's Q3 net profit up five times to Rs 194.76 crore
Hyderabad : City-based drug maker NATCO Pharma Limited said its consolidated net profit for the December quarter rose by 425 per cent to Rs 194.76 crore against Rs 37.04 crore during the same quarter last year, on back of US sales.
According to a statement issued by the company, total revenues for the December quarter stood at Rs 685.13 crore up 134 per cent against Rs 293.45 crore during October-December quarter in FY 16.
"The revenue and profit growth for the company during the quarter was driven predominantly by the sales of Oseltamivir product in the US market and includes profit sharing from our marketing partner," the statement added.
Natco shares closed at Rs 778.70 apiece on BSE, up 1.68 per cent over previous close.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd